An analytical comparison of cobalt cardiomyopathy and idiopathic dilated cardiomyopathy

Biological Trace Element Research

Volumn 55, Issue 1-2, 1996, Pages 21-30

  Centeno, Jose A ^a   Pestaner, Joseph P ^c   Mullick, Florabel G ^a   Virmani, Renu ^b  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b Cardiovascular Pathology   (United States)

^c Office of Chief Medical Examiner New York   (United States)

Author keywords

cobalt; Dilated cardiomyopathy; toxic cardiomyopathy

Indexed keywords

COBALT;

ARTICLE; CARDIOTOXICITY; COBALT THERAPY; CONGESTIVE CARDIOMYOPATHY; DIFFERENTIAL DIAGNOSIS; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; MUSCLE ATROPHY; MYOFIBROSIS;

EID: 0030465554     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02784165     Document Type: Article

References (21)

1. N. E. Kantrowitz and M. R. Bristow. Cardiotoxicity of antitumor agents, Prog. Card. Dis. 27, 195-200 (1984).
2. M. R. Bristow, P. D. Thompson, R. P. Martin, J. W. Mason, M. E. Billingham, and D. C. Harrison. Early anthracycline cardiotoxicity, Am. J. Med. 65, 823-832 (1978).
3. E. A. Lefrak, J. Pitha, S. Rosenheim and J. A. Gottlieb. A clinicopathologic analysis of adriamycin cardiotoxicity, Cancer 32, 302-314 (1973).
4. P. Bhanot, B. Cushing, A. Philippart, D. Lakshmi, and Z. Farooki. Hepatic irradiation and adriamycin cardiotoxicity. J. Peds. 95, 561-563 (1979).
5. C. E. Brown and D. H. McNamara. Acute interstitial myocarditis following administration of arsphenamines. Arch. Derm. Syph. 42, 312 (1940).
6. J. R. Edge. Myocardial fibrosis following arsenical therapy. Lancet 2, 675 (1946).
7. S. R. Greenberg, S. Burman, T. Casale, E. Millhouse, J. Kamarryt, W. Schumer. The pathology of experimental cobalt cardiomyopathy. Bulletin SPEP 5, 5-7 (1977).
8. N. Hatori, S. K. Pehrsson, N. Clyne et al. Acute cobalt exposure and oxygen radical scavengers in the rat myocardium. Biochimica et Biophysica Acta 1181, 257-260 (1993).
9. M. E. Billingham. Morphologic changes in drug-induced heart disease, in Drug-induced heart disease, M. R. Bristow ed, Elsevier, pp. 127-149 (1980).
10. Y. L. Morin, A. R. Foley, G. Martineau, and J. Roussel. Quebec Beer-Drinkers' Cardiomyopathy: Forty-eight cases. Can. Med. Assoc. J. 97, 881-883 (1967).
11. P. H. McDermott, R. L. Delaney, J. D. Egan, and J. F. Sullivan. Myocardosis and cardiac failure in men. J. Am. Med. Assoc. 198, 253-256 (1966).
12. C. S. Alexander. Cobalt beer cardiomyopathy. A clinical and pathologic study of twenty-eight cases. Am. J. Med. 53, 395-417 (1972).
13. H. Kesteloot, J. Roelandt, J. Willems, J. M. Class, and J. V. Joosens. An enquiry into the role of cobalt in the heart disease of chronic beer drinkers. Circulation 37, 854-864 (1968).
14. N. W. Revis. Relationship of vanadium, cadmium, lead, nickel, cobalt, and soft water to myocardial and vascular toxicity and cardiovascular disease. In: Cardiovascular toxicology, Van Stee EW (ed). Raven, New York, pp. 365-375 (1982).
15. J. Q. Jarvis, E. Hammond, R. Meier, and C. Robinson. Cobalt cardiomyopathy: a report of two cases from mineral assay laboratories and a review of the literature. J. Occup. Med. 34, 620-626 (1992).
16. H. A. McAllister and F. G. Mullick. The Cardiovascular System, in: Pathology of drug-induced and toxic diseases, R. H. Riddell, ed., Churchill Livingstone, New York, pp. 201-228 (1982).
17. N. S. Irey. Tissue reactions to drugs. Am. J. Pathol. 82, 617-647 (1976).
18. A. Kennedy, R. King, and J. D. Dornan. Fatal myocardial disease associated with industrial exposure to cobalt. Lancet 412-414 (1981).
19. J. Sullivan, M. Parker, and S. B. Carson. Tissue cobalt content in "beer drinkers" myocardiopathy. J. Lab. Clin. Med. 71, 893-896 (1968).
20. W. G. Hoekstra. Biochemical function of selenium and its relation to vitamin E. Fed. Proc. 34, 2083-2089 (1975).
21. J. F. Van Vleet, A. H. Relon, and V. J. Ferrans. Acute cobalt and isoproterenol cardiotoxicity in swine: Protection by selenium-vitamin E supplementation and potentiation by stress susceptible phenotype. Am. J. Vet. Res. 38, 991-1002 (1977).